Dr. Eric Matteson, M.D

NPI: 1982677563
Total Payments
$74,289
2024 Payments
$5,659
Companies
9
Transactions
64

Payment Breakdown by Category

Other$42,517 (57.2%)
Consulting$28,228 (38.0%)
Travel$1,909 (2.6%)
Research$1,211 (1.6%)
Food & Beverage$423.79 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $42,517 30 57.2%
Consulting Fee $28,228 15 38.0%
Travel and Lodging $1,909 7 2.6%
Unspecified $1,211 1 1.6%
Food and Beverage $423.79 11 0.6%

Payments by Type

General
$73,078
63 transactions
Research
$1,211
1 transactions

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim International GmbH $28,345 33 $0 (2023)
PFIZER INC. $14,651 1 $0 (2017)
Gilead Sciences, Inc. $11,852 18 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $7,678 5 $0 (2024)
Amgen Inc. $4,836 2 $0 (2018)
Boehringer Ingelheim Hong Kong Ltd. $2,000 1 $0 (2021)
Boehringer Ingelheim Do Brasil Quimica e Farmaceutical Ltda. $1,875 1 $0 (2020)
Boehringer Ingelheim Taiwan Ltd. $1,594 1 $0 (2021)
Horizon Therapeutics plc $1,458 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,659 1 Boehringer Ingelheim Pharmaceuticals, Inc. ($5,659)
2023 $8,346 7 Boehringer Ingelheim International GmbH ($6,462)
2022 $1,350 3 Boehringer Ingelheim International GmbH ($891.78)
2021 $11,878 14 Boehringer Ingelheim International GmbH ($7,149)
2020 $11,697 13 Boehringer Ingelheim International GmbH ($9,822)
2019 $12,520 20 Gilead Sciences, Inc. ($11,852)
2018 $8,188 5 Amgen Inc. ($4,836)
2017 $14,651 1 PFIZER INC. ($14,651)

All Payment Transactions

64 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
09/09/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $5,659.11 General
Category: RESPIRATORY
11/10/2023 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $695.13 General
Category: RESPIRATORY
10/08/2023 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $617.89 General
Category: RESPIRATORY
07/27/2023 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $265.52 General
Category: RESPIRATORY
05/02/2023 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $3,097.05 General
Category: RESPIRATORY
02/17/2023 Horizon Therapeutics plc Consulting Fee Cash or cash equivalent $1,000.00 General
02/05/2023 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $569.50 General
Category: RESPIRATORY
01/08/2023 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $2,100.50 General
Category: RESPIRATORY
11/12/2022 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $618.00 General
Category: RESPIRATORY
09/01/2022 Horizon Therapeutics plc Consulting Fee Cash or cash equivalent $458.33 General
08/16/2022 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $273.78 General
Category: RESPIRATORY
12/23/2021 Boehringer Ingelheim Hong Kong Ltd. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: RESPIRATORY
12/17/2021 Boehringer Ingelheim Taiwan Ltd. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,593.75 General
Category: RESPIRATORY
12/02/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $900.00 General
Category: RESPIRATORY
11/06/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $618.00 General
Category: RESPIRATORY
10/21/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: RESPIRATORY
10/07/2021 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $794.43 General
Category: RESPIRATORY
09/09/2021 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $341.38 General
Category: RESPIRATORY
09/03/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $900.00 General
Category: RESPIRATORY
08/18/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $271.75 General
Category: RESPIRATORY
06/03/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $635.00 General
Category: RESPIRATORY
05/20/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: RESPIRATORY
04/16/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: RESPIRATORY
04/16/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Consulting Fee Cash or cash equivalent $375.00 General
Category: RESPIRATORY
04/01/2021 Boehringer Ingelheim International GmbH OFEV (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $299.00 General
Category: RESPIRATORY

Research Studies & Clinical Trials

Study Name Company Amount Records
Simulating Population Disability Outcomes for Alternative Treatment Pathways in Patients With Active Rheumatoid Arthritis Amgen Inc. $1,211 1

About Dr. Eric Matteson, M.D

Dr. Eric Matteson, M.D is a Rheumatology healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982677563.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Matteson, M.D has received a total of $74,289 in payments from pharmaceutical and medical device companies, with $5,659 received in 2024. These payments were reported across 64 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,517).

Practice Information

  • Specialty Rheumatology
  • Location Rochester, MN
  • Active Since 02/13/2006
  • Last Updated 03/14/2018
  • Taxonomy Code 207RR0500X
  • Entity Type Individual
  • NPI Number 1982677563

Products in Payments

  • OFEV (Drug) $41,492
  • Enbrel (Biological) $4,836

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Rheumatology Doctors in Rochester